RENEWED: A follow-up study of the opicinumab phase 2 RENEW study in participants with acute optic neuritis.
Aktas O, Ziemssen F, Ziemssen T, Klistorner A, Butzkueven H, Izquierdo G, Leocani L, Balcer LJ, Galetta SL, Castrillo-Viguera C, Bradley DP, Naylor ML, Belachew S, Franchimont N, Zhu B, Cheng W; RENEWED Investigators.
Aktas O, et al. Among authors: galetta sl.
Mult Scler Relat Disord. 2024 Nov 24;93:106185. doi: 10.1016/j.msard.2024.106185. Online ahead of print.
Mult Scler Relat Disord. 2024.
PMID: 39662163
Free article.